Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 578
Quick answer
578 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7259167
Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
granted -
US 7259153
Drug formulation and delivery using crystalline methylated cyclodextrins
granted -
US 7259142
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
granted -
US 7259261
Racemization and enantiomer separation of clopidogrel
granted -
US 7259236
RBP1L1, a novel retinoblastoma binding protein-related gene encoding an antigenic epitope and methods of using thereof
granted -
US 7258863
Heterologous protection induced by immunization with invaplex vaccine
granted -
US 7258859
Method for the treatment of multiple sclerosis
granted -
US 7262218
Forms of pravastatin sodium
granted -
US 7261900
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted -
US 7262027
Polypeptide and DNA immunization against Coccidioides spp. infections
granted -
US 7261882
Methods for treating neuropathic pain by administering IL-10 polypeptides
granted -
US 7261875
Dendritic poly (amino acid) carriers and methods of use
granted -
US 7262185
Benzazepine derivative, process for producing the same, and use
granted -
US 7261896
Methods for preventing strokes by inducing tolerance to e-selectin
granted -
US 7262288
Nucleic acids encoding human telomerase reverse transcriptase and related homologs
granted -
US 7262205
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 7265157
Sustained release compositions, process for producing the same and use thereof
granted -
US 7264947
Activity dependent neurotrophic factor III (ADNF III)
granted -
US 7264798
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
granted -
US 7264820
Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokline
granted -
US 7265208
Fusion molecules and treatment of IgE-mediated allergic diseases
granted -
US 7265215
DNA or RNA encoding a recombinant dengue envelope protein
granted -
US 7265186
Multi-arm block copolymers as drug delivery vehicles
granted -
US 7265091
Methods and compositions for treating male erectile dysfunction
granted -
US 7265133
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 7265086
Glycopeptide carboxy-saccharide derivatives
granted -
US 7265083
Treatment of idiopathic pulmonary fibrosis using IP-10
granted -
US 7264816
Virulent systemic feline calicivirus
granted -
US 7264813
Therapeutic uses of Dunaliella powder
granted -
US 7264799
Use of heparinases to decrease inflammatory response
granted -
US 7264804
Kits for detecting anti-SIRS antibodies
granted -
US 7268148
Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
granted -
US 7268122
Use of oversulfated polysaccharides as inhibitors of HIV
granted -
US 7268232
Androgen receptor modulators and method of treating disease using the same
granted -
US 7268212
Ligand of G protein-coupled receptor protein and DNA thereof
granted -
US 7268136
Compositions useful as inhibitors of protein kinases
granted -
US 7267978
Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expression
granted -
US 7267823
Ebola peptides and immunogenic compositions containing same
granted -
US 7268222
Polynucleotides encoding human transporter proteins
granted -
US 7267941
Cyanovirin variant-polymer conjugates
granted -
US 7268118
Thymosin β4 compositions
granted -
US 7271186
Nanomolar β-lactamase inhibitors
granted -
US 7271148
Inhibition of cellular proteases
granted -
US 7271181
Inhibitors of p38
granted -
US 7271179
Inhibitors of JAK protein kinase
granted -
US 7271150
Modified growth hormone
granted -
US 7270960
Diagnosis of ovarian carcinomas
granted -
US 7270994
Lactobacillus casei Bd-II stain and used to reduce blood cholesterol
granted
Frequently asked questions
How many pharma patents expire in 2027?
578 published patents in our USPTO index have expiration dates falling in calendar year 2027.